Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach.
| Image |  |
|---|---|
| Description | scientific article published on 25 August 2015 |
| Author/s | |
| Publication date | August 25, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |